Migraine is a debilitating condition that can greatly impact quality of life. In order to mitigate its impact, clinicians must be able to accurately diagnose the condition and be prepared to help patients prevent attacks, as well as provide ongoing management. In this video lecture, an expert discusses symptoms and signs that differentiate migraine from other forms of headache, as well as when and how to use the different classes of medications for prevention and management.
Interactive video lecture
After completing this activity, participants should be better able to:
- Screen patients for migraine using current criteria
- Establish strategies for prevention and management of migraine
- Identify the appropriate use of available options for migraine prevention and treatment in clinical practice
NPs and PAs
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
NP Course Advisor: Susan Tiso, DNP, FNP-BC, University of California, Irvine, Irvine, California
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until August 30, 2022. PAs should only claim credit commensurate with the extent of their participation.
PA course advisor: Lawrence Herman, DMSc, MPA, PA-C, University of Lynchburg, Lynchburg, Virginia.
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This program was cosupported by educational grants from AbbVie Inc.; Amgen; Genentech, a member of the Roche Group; Incyte; and Merck.
This activity is supported by an educational grant from Amgen.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose to the audience all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Hindiyeh: consulting fees: Amgen, Eli Lilly, and Lundbeck.
Dr Herman: fees for non-CE/CME services: Novo Nordisk.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose, except Dr Herman as noted above.
Participants wishing to earn CE/CME credit must:
- View the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 67%.
The estimated time to complete this activity is 1.00 hour.
Release date: August 31, 2021
Expiration date: August 30, 2022
© 2021 Practicing Clinicians Exchange. All Rights Reserved. 102121C-7E